The role of nitric oxide synthase/nitric oxide in vascular smooth muscle control

Perfusion

Volumn 15, Issue 2, 2000, Pages 97-104

  Sanders, D Bradford ^a   Kelley, Tara ^a   Larson, Douglas ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRITE; ARGININE; GLYCERYL TRINITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

BIOCHEMISTRY; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL FUNCTION; HEART PERFUSION; HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0034068398     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910001500203     Document Type: Review

References (40)

1. Furchgott RF. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 1996; 276: 1186-88.
2. Mayer B, Werner ER. Why tetrahydrobiopterin? Nitric oxide biochemistry, molecular biology, and therapeutic implications. Adv Pharmacol 1995; 34: 251-61.
3. Sanders DB, Larson DF, Jablonowski C, Olson L. Differential expression of inducible nitric oxide synthase in septic shock. J Extracorp Technol 1999; 31: 118-24.
4. Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schm Arch Pharmacol 1995; 352: 351-64.
5. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
6. Hobbs AJ, Ignarro LJ. The nitric oxide-cyclic GMP signal transduction system. In: Zapol WM, Bloch KD eds. Nitric oxide and the lung. New York: Marcel Dekker, 1996: 1-35.
7. Ignarro LJ, Degnan JN, Baricos WH, Kadowitz PJ, Wolin MS. Activation of purified guanylate cyclase by nitric oxide requires heme: comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta 1982; 257: 13312-20.
8. Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 1985; 25: 171-91.
9. Ignarro LJ. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension 1990; 16: 477-83.
10. Pallas F, Larson DF. Cerebral blood flow in the diabetic patient. Perfusion 1996; 11: 363-70.
11. Schmidt HW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993; 1178: 153-75.
12. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 1993; 7: 328-38.
13. 2+ levels in cultured vascular smooth muscle. J Biol Chem 1989; 264: 16764-71.
14. + exchange in vascular smooth muscle cells in primary culture. J Biol Chem 1991; 266: 12337-41.
15. + exchange of heart sarcolemma. Eur J Biochem 1983; 132: 451-60.
16. Davies P. Flow mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519-60.
17. Ranjan V, Xiao Z, Diamond SL. Constitutive NOS expression in cultured endothelial cells is elevated by fliud shear stress. Am J Physiol 1995; 269: H550-55.
18. Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993; 264: H150-56.
19. Awolesi MA, Sessa WC, Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 1995; 96: 1449-54.
20. Redmond EM, Cahill PA, Sitzmann JV. Flow-mediated regulation of G-protein expression in cocultured vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 1998; 18: 75-83.
21. Levitski A, Bar-Sinai A. The regulation of adenyl cyclase by receptor G proteins. Pharmacol Ther 1991; 50: 271-83.
22. Helmreich EJ, Hofmann KP. Structure and function of proteins in G-protein coupled signal transfer. Biochem Biophys Acta 1996; 1286: 285-322.
23. Manopoulos VG, Lelkes PL. Cyclic strain and forskolin differentially induce cAMP production in phenotypically diverse endothelial cells. Biochem Biophys Res Commun 1993; 31: 1379-85.
24. Rosales OR, Sumpio BE. Changes in cyclic strain increase inositol triphosphate and diacylglycerol in endothelial cells. Am J Physiol 1992; 262: C956-62.
25. Frishman WH, Sonnenblick EH eds. Cardiovascular pharmacotherapeutics. New York: McGraw-Hill, 1997.
26. Makhoul RG, Wallace TC. L-Arginine improves endothelium-dependent vasorelaxation and reduces intimai hyperplasia after balloon angioplasty. Arterioscl Thromb 1994; 14: 938-43.
27. Shesely EG, Maeda N, Kim HS et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93: 13176-81.
28. Godecke A, Decking VKM, Ding Z et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 1998; 82: 186-94.
29. Ignarro LJ, Gruetter CA. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of 5-nitrosothiols. Biochim Biophys Acta 1980; 631: 221.
30. Fung HL, Sutton SC, Kamiya A. Blood vessel uptake and metabolism of organic nitrates in the rat. J Pharmacol Exp Ther 1984; 228: 334-41.
31. Fung HL. Pharmacokinetic determinants of nitrate action. Am J Med 1984; 76: 22-26.
32. Bundgaard H, Boesgaard S, Mortensen SA, Arendrup J. Effect of nitroglycerin in patients with increased PVR. Scand Cardiovasc J 1997; 31: 339-42.
33. Arkanac MB, Kersten JR, Wynsen JC, Nijhawan N, Warltier DC. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside, and nitroglycerin. Pharmacology 1996; 52: 92-100.
34. Elkayam U, Kulick D, McIntosh N, Roth A, Hsueh W, Rahimtoola SH. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 1987; 76: 577-84.
35. Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn. New York: Pergamon Press, 1990.
36. Stoelting RK. Pharmacology and physiology in anesthetic practice. Philadelphia, PA: JB Lippincott, 1991.
37. Dattilo JB, Dattilo MPM, Makhoul RG, Matsurra J, Spratt JA, Yager DR. Inducible nitric oxide synthase expression in human vein grafts. Am J Surgery 1997; 174: 177-80.
38. Wennmalm A, Benthin G, Edlund A et al. Metabolism and excretion of nitric oxide in humans. Circ Res 1993; 73: 1121-27.
39. Frostell CG, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Anesthesiology 1991; 75: 990-99.
40. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149: 538-51.